Recombinant clotting factor concentrates.
Lusher
J M
JM
Wayne State University School of Medicine, MI, USA.
D000818:Animals; D002460:Cell Line; D002986:Clinical Trials as Topic; D006224:Cricetinae; D016895:Culture Media, Serum-Free; D005164:Factor IX / Q000235:genetics / Q000302:isolation & purification / Q000627:therapeutic use*; D005167:Factor VII / Q000235:genetics / Q000627:therapeutic use*; D005169:Factor VIII / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000627:therapeutic use*; D015942:Factor VIIa; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007518:Isoantibodies / Q000096:biosynthesis / Q000235:genetics; D008647:Mesocricetus; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000627:therapeutic use; D017384:Sequence Deletion; D014162:Transfection
D016895:Culture Media, Serum-Free; D007518:Isoantibodies; D011994:Recombinant Proteins; C078147:F8 protein, human; D005167:Factor VII; D005169:Factor VIII; D005164:Factor IX; C103587:recombinant FVIIa; D015942:Factor VIIa